13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0002056786
Total reported value
$196.0M
$196.0M
10 檔
565.9%
In Q3 2025, Lunate Capital Ltd's U.S. equity holdings reached a combined market value of $196.0M, distributed across 10 disclosed stock positions.
In Q3 2025, Lunate Capital Ltd displayed an active expansion posture, initiating 5 new positions and adding to 1 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including SAIL, , CRWV) accounted for 565.9% of total reported equity market value during Q3 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SAIL | Sailpoint Inc | Stock-Other | 50.13% | -10.59% | +806.39% | |
| 2 | ✓ | Stock-Other | 19.29% | — | — | ||
| 3 | CRWV | Coreweave Inc-cl A | Stock-Tech | 11.56% | — | — | |
| 4 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 8.56% | -44.36% | EXIT | |
| 5 | NCMI | National Cinemedia Inc | Stock-Other | 3.07% | — | — | |
| 6 | CHYM | Chime Financial Inc-cl A | Stock-Other | 3.05% | — | — | |
| 7 | FIGR | Figure Technology Solut-cl A | Stock-Other | 2.06% | — | — | |
| 8 | LINE | Lineage Inc | Stock-Other | 1.94% | -3.09% | — | |
| 9 | NMRA | Neumora Therapeutics Inc | Stock-Other | 0.32% | -1.60% | — | |
| 10 | RVMDW | Revolution Medicines Inc-28 | Stock-Other | 0.01% | -0.67% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | +19.3% | NEW | New buy | |
| 2 | SAIL | Sailpoint Inc | +11.6% | +806.39% | Add |
| 3 | CRWV | Coreweave Inc-cl A | +11.6% | NEW | New buy |
| 4 | NCMI | National Cinemedia Inc | +3.1% | NEW | New buy |
| 5 | CHYM | Chime Financial Inc-cl A | +3.1% | NEW | New buy |
| 6 | FIGR | Figure Technology Solut-cl A | +2.1% | NEW | New buy |
| 7 | RVMDW | Revolution Medicines Inc-28 | -0.1% | — | Unchanged |
| 8 | IOT | Samsara Inc-cl A | -0.5% | EXIT | Sold out |
| 9 | NMRA | Neumora Therapeutics Inc | -0.6% | — | Unchanged |
| 10 | LINE | Lineage Inc | -12.7% | — | Unchanged |
| 11 | RVMD | Revolution Medicines Inc | -36.8% | — | Unchanged |
According to official SEC Form 13F filings, Lunate Capital Ltd reported a total U.S. public equity portfolio value of $196.0M across 10 disclosed positions in Q3 2025.
During Q3 2025, Lunate Capital Ltd's top holdings by market value included SAIL (50.1%)、 (19.3%)、CRWV (11.6%). The largest single position, SAIL, represented 50.1% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
市值: $231.1M
Top Position Liquidated / Trimmed
IOT
前期市值: $905.0K
In Q3 2025, Lunate Capital Ltd made 7 total portfolio adjustments, initiating 5 new buys, adding to 1 positions, trimming 0 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.